RE: 6 years and no product17 Jun 2020 12:25
I think if you look at any small emerging Pharma company the business model will be the same and a listing enables them to raise money to accelerate research and development until they develop and start selling that product. So the valuation on a stock market for these companies is very much based on potential and sentiment.
anyway forget that, sea of blue, MM's want your shares, train leaving, someone knows something, massive buy in the back ground, RNS imminent , etc etc